6-64307084-TGAGAGAGAGAGA-TGAGAGA
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM2BP6_Very_Strong
The NM_001142800.2(EYS):c.6079-8_6079-3del variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000901 in 872,158 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00013 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0011 ( 0 hom. )
Consequence
EYS
NM_001142800.2 splice_region, splice_polypyrimidine_tract, intron
NM_001142800.2 splice_region, splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.762
Genes affected
EYS (HGNC:21555): (eyes shut homolog) The product of this gene contains multiple epidermal growth factor (EGF)-like and LamG domains. The protein is expressed in the photoreceptor layer of the retina, and the gene is mutated in autosomal recessive retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 6-64307084-TGAGAGA-T is Benign according to our data. Variant chr6-64307084-TGAGAGA-T is described in ClinVar as [Benign]. Clinvar id is 726159.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EYS | NM_001142800.2 | c.6079-8_6079-3del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000503581.6 | NP_001136272.1 | |||
EYS | NM_001292009.2 | c.6079-8_6079-3del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_001278938.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EYS | ENST00000503581.6 | c.6079-8_6079-3del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 5 | NM_001142800.2 | ENSP00000424243 | A2 | |||
EYS | ENST00000370621.7 | c.6079-8_6079-3del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | ENSP00000359655 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000127 AC: 19AN: 149932Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
19
AN:
149932
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00106 AC: 767AN: 722226Hom.: 0 AF XY: 0.00109 AC XY: 410AN XY: 376678
GnomAD4 exome
AF:
AC:
767
AN:
722226
Hom.:
AF XY:
AC XY:
410
AN XY:
376678
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000127 AC: 19AN: 149932Hom.: 0 Cov.: 0 AF XY: 0.0000959 AC XY: 7AN XY: 73014
GnomAD4 genome
AF:
AC:
19
AN:
149932
Hom.:
Cov.:
0
AF XY:
AC XY:
7
AN XY:
73014
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Retinitis pigmentosa 25 Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 02, 2023 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 24, 2020 | - - |
EYS-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 06, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 21, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at